Results 111 to 120 of about 53,966 (218)

Efficacy and visual prognostic factors of intravitreal bevacizumab as needed for macular edema secondary to central retinal vein occlusion

, 2014
Miki Hirose, Wataru Matsumiya, Shigeru Honda, Makoto NakamuraDepartment of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Hyogo, JapanPurpose: Our aim was to investigate the efficacy and prognostic factors
Hirose M, Honda S, Nakamura M, Matsumiya W   +3 more
core  

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration

Journal of Ophthalmic & Vision Research, 2010
Purpose: To evaluate the results of intravitreal expansile gas injection, with or without recombinant tissue plasminogen activator (rtPA), followed by intravitreal bevacizumab injection for treatment of submacular hemorrhage (SMH) secondary to ...
Ramin Nourinia, Mohammad Bonyadi, Hamid Ahmadieh   +2 more
doaj  

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Intravitreal bevacizumab has initial clinical benefit lasting eight weeks in eyes with neovascular age-related macular degeneration

, 2008
P William Conrad, David N Zacks, Mark W JohnsonDepartment of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USAPurpose: To determine whether the effect of a single initial intravitreal injection of ...
P William Conrad, Mark W Johnson, David N Zacks   +2 more
core  

Assessment of Anterior Chamber Inflammation after Intravitreal Bevacizumab Injection in Different Ocular Exudative Diseases

, 2011
PURPOSE. To investigate the inflammation of the anterior chamber after intravitreal bevacizumab injection in different ocular exudative ...
Samuray Tuncer, Baris Yeniad, Tuncer, Samuray, Kir, Nur, Ovali, Tunc, Koray Akarcay, Tugal-Tutkun, Ilknur, Ilknur Tugal-Tutkun, Akarcay, Koray, Yeniad, Baris, Ozen Ayranci, Tunc Ovali, Ayranci, Ozen, Nur Kir   +13 more
core   +1 more source

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions

, 2017
Biljana Ivanovska Adjievska,1 Salih Boskurt,1 Nikola Orovcanec,2 Vesna Dimovska-Jordanova3 1Department for Posterior Segment, European Eye Hospital, Skopje, Republic of Macedonia; 2Department for Medical Statistics, Institute for Epidemiology and ...
Ivanovska Adjievska B, Dimovska-Jordanova V, Boskurt S, Orovcanec N   +3 more
core  

Pneumatic displacement and intravitreal bevacizumab: A new approach for management of submacular hemorrhage in choroidal neovascular membrane

Indian Journal of Ophthalmology, 2009
Choroidal neovascular membrane (CNVM) is one of the most common causes of submacular hemorrhage (SMH). Conventional treatment involves management of the SMH with pneumatic displacement with or without tissue plasminogen activator (TPA) followed by ...
Chawla Shobhit, Misra Vishal, Khemchandani Mohit   +2 more
doaj  

CHANGES IN MACULAR THICKNESS AND VISUAL ACUITY AFTER INTRAVITREAL BEVACIZUMAB INJECTION IN PATIENTS WITH RETINAL VEIN OCCLUSION

Pakistan Armed Forces Medical Journal, 2014
Objective: To evaluate the effect of single Intravitreal Bevacizumab (Avastin) injection on visual acuity (VA) and central retinal thickness (CRT) in patients with macular edema secondary to branch retinal vein occlusion (BRVO) or central retinal vein ...
Naveed Ahmed Qureshi, Sarah A Zafar, Muhammad Kamran Khalid, Nadeem Qureshi, Fareeha Ambreen   +4 more
doaj   +2 more sources

Intravitreal bevacizumab

Indian Journal of Ophthalmology, 2018
openaire   +3 more sources